These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19177016)

  • 1. A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction.
    Timp W; Levchenko A; Feinberg AP
    Cell Cycle; 2009 Feb; 8(3):383-90. PubMed ID: 19177016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
    Kaneda A; Wang CJ; Cheong R; Timp W; Onyango P; Wen B; Iacobuzio-Donahue CA; Ohlsson R; Andraos R; Pearson MA; Sharov AA; Longo DL; Ko MS; Levchenko A; Feinberg AP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20926-31. PubMed ID: 18087038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
    Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
    J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.
    Sakatani T; Kaneda A; Iacobuzio-Donahue CA; Carter MG; de Boom Witzel S; Okano H; Ko MS; Ohlsson R; Longo DL; Feinberg AP
    Science; 2005 Mar; 307(5717):1976-8. PubMed ID: 15731405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer.
    Cui H
    Dis Markers; 2007; 23(1-2):105-12. PubMed ID: 17325430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
    Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
    Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network.
    Vanaja KG; Timp W; Feinberg AP; Levchenko A
    Mol Cell; 2018 Oct; 72(1):60-70.e3. PubMed ID: 30244832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
    Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
    Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
    Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
    Kaneda A; Feinberg AP
    Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
    Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
    Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
    Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
    J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
    Ying Y; Tao Q
    Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic approach to cancer epigenetics.
    Feinberg AP
    Cold Spring Harb Symp Quant Biol; 2005; 70():335-41. PubMed ID: 16869770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.